Page last updated: 2024-08-24

nelfinavir and Cancer, Second Primary

nelfinavir has been researched along with Cancer, Second Primary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bridgewater, J; Corrie, PG; Hawkins, M; Hurt, CN; Maughan, T; Mukherjee, S; O'Neill, E; Parsons, P; Patel, N; Radhakrishna, G; Sebag-Montefiore, D; Shaw, R; Strauss, VY; Tranter, B; Virdee, PS; Ward, E	1

Trials

1 trial(s) available for nelfinavir and Cancer, Second Primary

Article	Year
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2). BMC cancer, 2019, Feb-04, Volume: 19, Issue:1 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Combined Modality Therapy; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Nelfinavir; Neoplasms, Second Primary; Pancreatic Neoplasms; Radiation Dosage; Survival Analysis; Treatment Outcome; Young Adult	2019

Article

Year

Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2).

BMC cancer, 2019, Feb-04, Volume: 19, Issue:1

Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Combined Modality Therapy; Female; Humans; Induction Chemotherapy; Male; Middle Aged; Nelfinavir; Neoplasms, Second Primary; Pancreatic Neoplasms; Radiation Dosage; Survival Analysis; Treatment Outcome; Young Adult

2019